Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses (Q79394815)
Jump to navigation
Jump to search
scientific article published on 30 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses |
scientific article published on 30 November 2006 |
Statements
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses (English)
Kazuhiko Nakagawa
Takayasu Kurata
Taroh Satoh
Toshiji Nogami
Koji Takeda
Shigeki Mitsuoka
Naruo Yoshimura
Shinzoh Kudoh
Shunichi Negoro
Masahiro Fukuoka
30 November 2006